Market Place
Sourcing Support
Enforcement Report - Week of November 13, 2024
13 Nov 2024 //
FDA
Indies Pharma`s Generics Regadenoson Receives Approval in US
22 Aug 2024 //
FDA
GE Healthcare`s Generics Regadenoson Receives Approval in US
05 Aug 2024 //
FDA
Astellas Confirms Final Federal Circuit Decision in LEXISCAN Patent Appeal
12 May 2023 //
PRESS RELEASE
Dr Reddy`s Laboratories launches Regadenoson injection in US market
05 May 2023 //
ECONOMICTIMES
Mylan`s Generic Regadenoson MonohydrateReceives Approval in the U.S.
04 Apr 2023 //
FDA
Hikma`s Generic Regadenoson Receives Approval in the U.S.
02 Feb 2023 //
FDA
Appeals court sides with Pfizer in patent fight with Astellas
05 Jan 2023 //
FIERCE PHARMA
Eugia`s Generic Regadenoson Monohydrate Receives Approval in the U.S.
26 Oct 2022 //
FDA
Hospira must wait to launch generic Lexiscan—but only two weeks
27 Sep 2022 //
FIERCEPHARMA
Hospira`s Generic Regadenoson Receives Approval in the U.S.
31 Aug 2022 //
FDA
Delaware court rules against Gilead and Astellas in years-long patent case
23 May 2022 //
ENDPTS
Accord Healthcare`s Generic Regadenoson Receives Approval in the U.S.
11 Apr 2022 //
FDA
Dr. Reddy`s Generic Regadenoson Receives Approval in the U.S.
11 Apr 2022 //
FDA
Hong Kong`s Generic Regadenoson Receives Approval in the U.S.
11 Apr 2022 //
FDA
Apotex`s Generic Regadenoson Receives Approval in the U.S.
11 Apr 2022 //
FDA
GE Healthcare’s Stress Agent Rapiscan Approved for use in Imaging Modalities
14 Feb 2022 //
BUSINESSWIRE
Dr Reddys Labs Ltd`s Generic Regadenoson Receives Tentative Approval In US
21 Jan 2021 //
FDA
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Sun Pharma
01 Nov 2018 //
PATENT LITIGATION
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.